BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 20, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for April 15, 2025

April 15, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Avernus, Evenus, Fresenius Kabi, Hengrui, Kalvista, Kaken, Oncozenge, Opthea, Pacira.
Read More

Other news to note for April 14, 2025

April 14, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Carmat, Elutia, Sequana Medical, Vicarious Surgical.
Read More

Other news to note for April 14, 2025

April 14, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avernus, Opthea, Oncozenge.
Read More

Other news to note for April 11, 2025

April 11, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Basel Medical Group, Biosymetrics, Bethesda Medical, Cagent Vascular, Daxor, Green Earth Biomedical, Keensight Capital, Motion Informatics, Niox.
Read More

Other news to note for April 11, 2025

April 11, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atossa, Keros, Nona, Revive, Tempest, Tevogen, Torpedo.
Read More

Other news to note for April 10, 2025

April 10, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Chemeleon, Drummond, GE Healthcare, Innoblative, Nextech, Ocuco, Ondine, Prapela.
Read More

Other news to note for April 10, 2025

April 10, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaxis, Ayala, Biosymetrics, Makana, OS Therapies, QumulusAI, Renovaro, Tonix, Vincerx.
Read More

Other news to note for April 10, 2025

April 10, 2025
Additional early-stage research and drug discovery news in brief, from: Rondo Therapeutics.
Read More

Other news to note for April 9, 2025

April 9, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Baird, Cepheid, Danaher, Nyxoah, Oxford Nanopore, Paige, Sectra, Shine.
Read More

Other news to note for April 9, 2025

April 9, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Defence, Evenus, Fresenius Kabi, Hengrui, Kaken, Kalvista, Ocuvex, Onconetix, Pacira, Synthego, Vita.
Read More
Previous 1 2 … 56 57 58 59 60 61 62 63 64 … 1400 1401 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing